| pubmed-article:7524463 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7524463 | lifeskim:mentions | umls-concept:C0007807 | lld:lifeskim |
| pubmed-article:7524463 | lifeskim:mentions | umls-concept:C0027820 | lld:lifeskim |
| pubmed-article:7524463 | lifeskim:mentions | umls-concept:C0009010 | lld:lifeskim |
| pubmed-article:7524463 | lifeskim:mentions | umls-concept:C0028768 | lld:lifeskim |
| pubmed-article:7524463 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:7524463 | lifeskim:mentions | umls-concept:C2709058 | lld:lifeskim |
| pubmed-article:7524463 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
| pubmed-article:7524463 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:7524463 | pubmed:dateCreated | 1994-10-21 | lld:pubmed |
| pubmed-article:7524463 | pubmed:abstractText | This study examined the effect of long-term (mean, 19 months) treatment with clomipramine hydrochloride on cerebrospinal fluid (CSF) levels of several neuropeptides and monoamine metabolites in children and adolescents with obsessive-compulsive disorder. | lld:pubmed |
| pubmed-article:7524463 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7524463 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7524463 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7524463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7524463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7524463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7524463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7524463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7524463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7524463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7524463 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7524463 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7524463 | pubmed:issn | 0003-990X | lld:pubmed |
| pubmed-article:7524463 | pubmed:author | pubmed-author:PotterW ZWZ | lld:pubmed |
| pubmed-article:7524463 | pubmed:author | pubmed-author:RichterDD | lld:pubmed |
| pubmed-article:7524463 | pubmed:author | pubmed-author:RapoportJ LJL | lld:pubmed |
| pubmed-article:7524463 | pubmed:author | pubmed-author:LeonardH LHL | lld:pubmed |
| pubmed-article:7524463 | pubmed:author | pubmed-author:SwedoS ESE | lld:pubmed |
| pubmed-article:7524463 | pubmed:author | pubmed-author:AltemusMM | lld:pubmed |
| pubmed-article:7524463 | pubmed:author | pubmed-author:RubinowD RDR | lld:pubmed |
| pubmed-article:7524463 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7524463 | pubmed:volume | 51 | lld:pubmed |
| pubmed-article:7524463 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7524463 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7524463 | pubmed:pagination | 794-803 | lld:pubmed |
| pubmed-article:7524463 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:meshHeading | pubmed-meshheading:7524463-... | lld:pubmed |
| pubmed-article:7524463 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7524463 | pubmed:articleTitle | Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. | lld:pubmed |
| pubmed-article:7524463 | pubmed:affiliation | Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md. | lld:pubmed |
| pubmed-article:7524463 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7524463 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7524463 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7524463 | lld:pubmed |
